Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology Equipment

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1612861

Cover Image

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1612861

Host Cell Contaminant Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

PUBLISHED:
PAGES: 198 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4900
PDF & Excel (Multi User License)
USD 6400
PDF & Excel (Corporate User License)
USD 7400

Add to Cart

Description

Table of Contents

Persistence Market Research has recently released a comprehensive report on the global host cell contaminant testing market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Host Cell Contaminant Testing Market Size (2024E): US$ 328.3 Mn
  • Projected Market Value (2031F): US$ 478.8 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031): 5.5%

Host Cell Contaminant Testing Market - Report Scope:

Host cell proteins refer to a diverse group of proteins derived from host cells such as yeast, E. coli, and mammals. These proteins exhibit significant differences in properties, isoelectric points, and molecular masses. The identification and quantification of host cell contaminants are crucial during biopharmaceutical development. A wide array of techniques, including immuno-specific methods like ELISA, Western Blot, and PCR, as well as non-specific methods like electrophoresis and LC-MS, are utilized to ensure the purity of biopharmaceutical samples. The ideal approach combines high throughput and quantitative analysis to identify all types of contaminants effectively.

Market Drivers:

The demand for efficient host cell contaminant testing methods is primarily driven by the growing need for quality assurance in biopharmaceuticals. As the industry continues to expand, there is a heightened emphasis on ensuring the safety, efficacy, and regulatory compliance of products. Advances in detection technologies, such as next-generation sequencing and high-resolution mass spectrometry, further propel market growth by offering precise and reliable results. Additionally, the increasing prevalence of chronic diseases and the rise in biosimilar development are amplifying the importance of rigorous contaminant testing protocols.

Market Restraints:

Despite the promising growth prospects, the market faces certain challenges. High costs associated with advanced testing methods and equipment can act as barriers, especially for smaller companies and academic institutions. Furthermore, the lack of standardization in testing protocols across regions leads to inconsistencies, impacting global compliance efforts. These factors can limit market expansion, particularly in emerging economies where cost-effectiveness is a critical consideration.

Market Opportunities:

The market holds significant opportunities, particularly in the integration of automation and artificial intelligence in contaminant testing processes. Automated systems not only enhance throughput but also minimize human error, ensuring higher accuracy. Collaborations between biopharmaceutical companies and contract research organizations present another growth avenue, enabling efficient resource utilization and expertise sharing. Furthermore, increasing regulatory stringency worldwide is likely to drive the adoption of more advanced and comprehensive testing solutions.

Competitive Intelligence and Business Strategy:

The global host cell contaminant testing market is characterized by the presence of key players focusing on innovation, strategic collaborations, and geographic expansion. Leading companies are investing in research and development to offer cutting-edge solutions, ensuring precision and efficiency in contaminant detection. Partnerships between large-scale pharmaceutical firms and smaller biopharmaceutical entities are fostering market growth, enabling the introduction of novel testing methodologies.

.

Key Companies Profiled:

  • BioGenes GmbH
  • Bio-Rad Laboratories, Inc.
  • Cisbio Bioassays
  • Cygnus Technologies LLC (A Maravai Lifesciences Company)
  • Enzo Life Sciences, Inc.
  • ForteBio (A Pall Company)
  • GE Healthcare Life Sciences
  • Molecular Devices LLC
  • ProteinSimple (A BioTechne Brand)
  • Thermo Fisher Scientific, Inc.
  • Others

Host Cell Contaminant Testing Market Segmentation:

By Product Type:

  • PCR-based Assays
  • ELISA-based Assays

By Platform:

  • Microbial
  • Mammalian
  • Others

By Application:

  • Research & Development
  • Clinical Applications

By End User:

  • Biopharmaceutical Companies
  • Contract Research Organizations
  • Contract Manufacturing Organizations
  • Academic & Research Institutes

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
Show more
Product Code: PMRREP21355

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy

3. Host Cell Contaminant Testing Market Opportunity Analysis

  • 3.1. Macro-Economic Factors
  • 3.2. Opportunity Analysis
  • 3.3. Market Dynamics

4. North America Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 4.1. Introduction
  • 4.2. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019 - 2023
    • 4.2.1. U.S.
    • 4.2.2. Canada
  • 4.3. Market Size (US$ Mn ) Forecast By Country, 2024 - 2031
    • 4.3.1. U.S.
    • 4.3.2. Canada
  • 4.4. Historical Market Size (US$ Mn ) Trend Analysis By Product Type, 2019 - 2023
    • 4.4.1. PCR-based Assays
    • 4.4.2. ELISA-based Assays
  • 4.5. Market Size (US$ Mn ) Forecast By Product Type, 2024 - 2031
    • 4.5.1. PCR-based Assays
    • 4.5.2. ELISA-based Assays
  • 4.6. Historical Market Size (US$ Mn ) Trend Analysis By Platform, 2019 - 2023
    • 4.6.1. Microbial
    • 4.6.2. Mammalian
    • 4.6.3. Others
  • 4.7. Market Size (US$ Mn ) Forecast By Platform, 2024 - 2031
    • 4.7.1. Microbial
    • 4.7.2. Mammalian
    • 4.7.3. Others
  • 4.8. Historical Market Size (US$ Mn ) Trend Analysis By Application, 2019 - 2023
    • 4.8.1. Research & Development
    • 4.8.2. Clinical Applications
  • 4.9. Market Size (US$ Mn ) Forecast By Application, 2024 - 2031
    • 4.9.1. Research & Development
    • 4.9.2. Clinical Applications
  • 4.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019 - 2023
    • 4.10.1. Biopharmaceutical Companies
    • 4.10.2. Contract Research Organizations
    • 4.10.3. Contract Manufacturing Organizations
    • 4.10.4. Academic & Research Institutes
  • 4.11. Market Size (US$ Mn ) Forecast By End User, 2024 - 2031
    • 4.11.1. Biopharmaceutical Companies
    • 4.11.2. Contract Research Organizations
    • 4.11.3. Contract Manufacturing Organizations
    • 4.11.4. Academic & Research Institutes
  • 4.12. Drivers and Restraints: Impact Analysis
  • 4.13. Market Attractiveness Analysis
    • 4.13.1. By Country
    • 4.13.2. By Product Type
    • 4.13.3. By Platform
    • 4.13.4. By Application
    • 4.13.5. By End User
  • 4.14. Key Representative Market Participants
  • 4.15. Market Presence (Intensity Map)

5. Latin America Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 5.1. Introduction
  • 5.2. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019 - 2023
    • 5.2.1. Brazil
    • 5.2.2. Mexico
    • 5.2.3. Rest of Latin America
  • 5.3. Market Size (US$ Mn ) Forecast By Country, 2024 - 2031
    • 5.3.1. Brazil
    • 5.3.2. Mexico
    • 5.3.3. Rest of Latin America
  • 5.4. Historical Market Size (US$ Mn ) Trend Analysis By Product Type, 2019 - 2023
    • 5.4.1. PCR-based Assays
    • 5.4.2. ELISA-based Assays
  • 5.5. Market Size (US$ Mn ) Forecast By Product Type, 2024 - 2031
    • 5.5.1. PCR-based Assays
    • 5.5.2. ELISA-based Assays
  • 5.6. Historical Market Size (US$ Mn ) Trend Analysis By Platform, 2019 - 2023
    • 5.6.1. Microbial
    • 5.6.2. Mammalian
    • 5.6.3. Others
  • 5.7. Market Size (US$ Mn ) Forecast By Platform, 2024 - 2031
    • 5.7.1. Microbial
    • 5.7.2. Mammalian
    • 5.7.3. Others
  • 5.8. Historical Market Size (US$ Mn ) Trend Analysis By Application, 2019 - 2023
    • 5.8.1. Research & Development
    • 5.8.2. Clinical Applications
  • 5.9. Market Size (US$ Mn ) Forecast By Application, 2024 - 2031
    • 5.9.1. Research & Development
    • 5.9.2. Clinical Applications
  • 5.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019 - 2023
    • 5.10.1. Biopharmaceutical Companies
    • 5.10.2. Contract Research Organizations
    • 5.10.3. Contract Manufacturing Organizations
    • 5.10.4. Academic & Research Institutes
  • 5.11. Market Size (US$ Mn ) Forecast By End User, 2024 - 2031
    • 5.11.1. Biopharmaceutical Companies
    • 5.11.2. Contract Research Organizations
    • 5.11.3. Contract Manufacturing Organizations
    • 5.11.4. Academic & Research Institutes
  • 5.12. Drivers and Restraints: Impact Analysis
  • 5.13. Market Attractiveness Analysis
    • 5.13.1. By Country
    • 5.13.2. By Product Type
    • 5.13.3. By Platform
    • 5.13.4. By Application
    • 5.13.5. By End User
  • 5.14. Key Representative Market Participants
  • 5.15. Market Presence (Intensity Map)

6. Europe Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 6.1. Introduction
  • 6.2. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019 - 2023
    • 6.2.1. Germany
    • 6.2.2. U.K.
    • 6.2.3. France
    • 6.2.4. Italy
    • 6.2.5. Spain
    • 6.2.6. Russia
    • 6.2.7. Rest of Europe
  • 6.3. Market Size (US$ Mn ) Forecast By Country, 2024 - 2031
    • 6.3.1. Germany
    • 6.3.2. U.K.
    • 6.3.3. France
    • 6.3.4. Italy
    • 6.3.5. Spain
    • 6.3.6. Russia
    • 6.3.7. Rest of Europe
  • 6.4. Historical Market Size (US$ Mn ) Trend Analysis By Product Type, 2019 - 2023
    • 6.4.1. PCR-based Assays
    • 6.4.2. ELISA-based Assays
  • 6.5. Market Size (US$ Mn ) Forecast By Product Type, 2024 - 2031
    • 6.5.1. PCR-based Assays
    • 6.5.2. ELISA-based Assays
  • 6.6. Historical Market Size (US$ Mn ) Trend Analysis By Platform, 2019 - 2023
    • 6.6.1. Microbial
    • 6.6.2. Mammalian
    • 6.6.3. Others
  • 6.7. Market Size (US$ Mn ) Forecast By Platform, 2024 - 2031
    • 6.7.1. Microbial
    • 6.7.2. Mammalian
    • 6.7.3. Others
  • 6.8. Historical Market Size (US$ Mn ) Trend Analysis By Application, 2019 - 2023
    • 6.8.1. Research & Development
    • 6.8.2. Clinical Applications
  • 6.9. Market Size (US$ Mn ) Forecast By Application, 2024 - 2031
    • 6.9.1. Research & Development
    • 6.9.2. Clinical Applications
  • 6.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019 - 2023
    • 6.10.1. Biopharmaceutical Companies
    • 6.10.2. Contract Research Organizations
    • 6.10.3. Contract Manufacturing Organizations
    • 6.10.4. Academic & Research Institutes
  • 6.11. Market Size (US$ Mn ) Forecast By End User, 2024 - 2031
    • 6.11.1. Biopharmaceutical Companies
    • 6.11.2. Contract Research Organizations
    • 6.11.3. Contract Manufacturing Organizations
    • 6.11.4. Academic & Research Institutes
  • 6.12. Drivers and Restraints: Impact Analysis
  • 6.13. Market Attractiveness Analysis
    • 6.13.1. By Country
    • 6.13.2. By Product Type
    • 6.13.3. By Platform
    • 6.13.4. By Application
    • 6.13.5. By End User
  • 6.14. Key Representative Market Participants
  • 6.15. Market Presence (Intensity Map)

7. Asia Pacific Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 7.1. Introduction
  • 7.2. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019 - 2023
    • 7.2.1. China
    • 7.2.2. Japan
    • 7.2.3. India
    • 7.2.4. ASEAN
    • 7.2.5. Australia and New Zealand
    • 7.2.6. Rest of Asia Pacific
  • 7.3. Market Size (US$ Mn ) Forecast By Country, 2024 - 2031
    • 7.3.1. China
    • 7.3.2. Japan
    • 7.3.3. India
    • 7.3.4. ASEAN
    • 7.3.5. Australia and New Zealand
    • 7.3.6. Rest of Asia Pacific
  • 7.4. Historical Market Size (US$ Mn ) Trend Analysis By Product Type, 2019 - 2023
    • 7.4.1. PCR-based Assays
    • 7.4.2. ELISA-based Assays
  • 7.5. Market Size (US$ Mn ) Forecast By Product Type, 2024 - 2031
    • 7.5.1. PCR-based Assays
    • 7.5.2. ELISA-based Assays
  • 7.6. Historical Market Size (US$ Mn ) Trend Analysis By Platform, 2019 - 2023
    • 7.6.1. Microbial
    • 7.6.2. Mammalian
    • 7.6.3. Others
  • 7.7. Market Size (US$ Mn ) Forecast By Platform, 2024 - 2031
    • 7.7.1. Microbial
    • 7.7.2. Mammalian
    • 7.7.3. Others
  • 7.8. Historical Market Size (US$ Mn ) Trend Analysis By Application, 2019 - 2023
    • 7.8.1. Research & Development
    • 7.8.2. Clinical Applications
  • 7.9. Market Size (US$ Mn ) Forecast By Application, 2024 - 2031
    • 7.9.1. Research & Development
    • 7.9.2. Clinical Applications
  • 7.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019 - 2023
    • 7.10.1. Biopharmaceutical Companies
    • 7.10.2. Contract Research Organizations
    • 7.10.3. Contract Manufacturing Organizations
    • 7.10.4. Academic & Research Institutes
  • 7.11. Market Size (US$ Mn ) Forecast By End User, 2024 - 2031
    • 7.11.1. Biopharmaceutical Companies
    • 7.11.2. Contract Research Organizations
    • 7.11.3. Contract Manufacturing Organizations
    • 7.11.4. Academic & Research Institutes
  • 7.12. Drivers and Restraints: Impact Analysis
  • 7.13. Market Attractiveness Analysis
    • 7.13.1. By Country
    • 7.13.2. By Product Type
    • 7.13.3. By Platform
    • 7.13.4. By Application
    • 7.13.5. By End User
  • 7.14. Key Representative Market Participants
  • 7.15. Market Presence (Intensity Map)

8. Middle East & Africa Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019 - 2023
    • 8.2.1. GCC Countries
    • 8.2.2. South Africa
    • 8.2.3. North Africa
    • 8.2.4. Rest of MEA
  • 8.3. Market Size (US$ Mn ) Forecast By Country, 2024 - 2031
    • 8.3.1. GCC Countries
    • 8.3.2. South Africa
    • 8.3.3. North Africa
    • 8.3.4. Rest of MEA
  • 8.4. Historical Market Size (US$ Mn ) Trend Analysis By Product Type, 2019 - 2023
    • 8.4.1. PCR-based Assays
    • 8.4.2. ELISA-based Assays
  • 8.5. Market Size (US$ Mn ) Forecast By Product Type, 2024 - 2031
    • 8.5.1. PCR-based Assays
    • 8.5.2. ELISA-based Assays
  • 8.6. Historical Market Size (US$ Mn ) Trend Analysis By Platform, 2019 - 2023
    • 8.6.1. Microbial
    • 8.6.2. Mammalian
    • 8.6.3. Others
  • 8.7. Market Size (US$ Mn ) Forecast By Platform, 2024 - 2031
    • 8.7.1. Microbial
    • 8.7.2. Mammalian
    • 8.7.3. Others
  • 8.8. Historical Market Size (US$ Mn ) Trend Analysis By Application, 2019 - 2023
    • 8.8.1. Research & Development
    • 8.8.2. Clinical Applications
  • 8.9. Market Size (US$ Mn ) Forecast By Application, 2024 - 2031
    • 8.9.1. Research & Development
    • 8.9.2. Clinical Applications
  • 8.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019 - 2023
    • 8.10.1. Biopharmaceutical Companies
    • 8.10.2. Contract Research Organizations
    • 8.10.3. Contract Manufacturing Organizations
    • 8.10.4. Academic & Research Institutes
  • 8.11. Market Size (US$ Mn ) Forecast By End User, 2024 - 2031
    • 8.11.1. Biopharmaceutical Companies
    • 8.11.2. Contract Research Organizations
    • 8.11.3. Contract Manufacturing Organizations
    • 8.11.4. Academic & Research Institutes
  • 8.12. Drivers and Restraints: Impact Analysis
  • 8.13. Market Attractiveness Analysis
    • 8.13.1. By Country
    • 8.13.2. By Product Type
    • 8.13.3. By Platform
    • 8.13.4. By Application
    • 8.13.5. By End User
  • 8.14. Key Representative Market Participants
  • 8.15. Market Presence (Intensity Map)

9. Forecast Factors: Relevance and Impact

10. Forecast Assumptions

11. Competition Landscape

  • 11.1. Competition Dashboard
  • 11.2. Company Profiles (Details - Overview, Financials, Strategy, SWOT, Recent Developments)
    • 11.2.1. BioGenes GmbH
    • 11.2.2. Bio-Rad Laboratories, Inc.
    • 11.2.3. Cisbio Bioassays
    • 11.2.4. Cygnus Technologies LLC (A Maravai Lifesciences Company)
    • 11.2.5. Enzo Life Sciences, Inc.
    • 11.2.6. ForteBio (A Pall Company)
    • 11.2.7. GE Healthcare Life Sciences
    • 11.2.8. Molecular Devices LLC
    • 11.2.9. ProteinSimple (A BioTechne Brand)
    • 11.2.10. Thermo Fisher Scientific, Inc.

12. Global Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Region

  • 12.1. Introduction/Key Findings
  • 12.2. Historical Market Size (US$ Mn ) Trend Analysis By Region, 2019 - 2023
    • 12.2.1. North America
    • 12.2.2. Latin America
    • 12.2.3. Europe
    • 12.2.4. Asia Pacific
    • 12.2.5. Middle East & Africa
  • 12.3. Market Size (US$ Mn ) Forecast By Region, 2024 - 2031
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. Asia Pacific
    • 12.3.5. Middle East & Africa
  • 12.4. Market Attractiveness Analysis By Region

13. Global Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Product Type

  • 13.1. Introduction/Key Findings
  • 13.2. Historical Market Size (US$ Mn ) Trend Analysis By Product Type, 2019 - 2023
    • 13.2.1. PCR-based Assays
    • 13.2.2. ELISA-based Assays
  • 13.3. Market Size (US$ Mn ) Forecast By Product Type, 2024 - 2031
    • 13.3.1. PCR-based Assays
    • 13.3.2. ELISA-based Assays
  • 13.4. Market Attractiveness Analysis By Product Type

14. Global Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Platform

  • 14.1. Introduction/Key Findings
  • 14.2. Historical Market Size (US$ Mn ) Trend Analysis By Platform, 2019 - 2023
    • 14.2.1. Microbial
    • 14.2.2. Mammalian
    • 14.2.3. Others
  • 14.3. Market Size (US$ Mn ) Forecast By Platform, 2024 - 2031
    • 14.3.1. Microbial
    • 14.3.2. Mammalian
    • 14.3.3. Others
  • 14.4. Market Attractiveness Analysis By Platform

15. Global Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Application

  • 15.1. Introduction/Key Findings
  • 15.2. Historical Market Size (US$ Mn ) Trend Analysis By Application, 2019 - 2023
    • 15.2.1. Research & Development
    • 15.2.2. Clinical Applications
  • 15.3. Market Size (US$ Mn ) Forecast By Application, 2024 - 2031
    • 15.3.1. Research & Development
    • 15.3.2. Clinical Applications
  • 15.4. Market Attractiveness Analysis By Application

16. Global Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By End User

  • 16.1.Introduction/Key Findings
  • 16.2. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019 - 2023
    • 16.2.1. Biopharmaceutical Companies
    • 16.2.2. Contract Research Organizations
    • 16.2.3. Contract Manufacturing Organizations
    • 16.2.4. Academic & Research Institutes
  • 16.3. Market Size (US$ Mn ) Forecast By End User, 2024 - 2031
    • 16.3.1. Biopharmaceutical Companies
    • 16.3.2. Contract Research Organizations
    • 16.3.3. Contract Manufacturing Organizations
    • 16.3.4. Academic & Research Institutes
  • 16.4. Market Attractiveness Analysis By End User

17. Global Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 17.1. Market Size and Y-o-Y Growth
  • 17.2. Absolute $ Opportunity

18. Research Methodology

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!